Clinical Trial Update: Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II) [NA]

View source ↗

Summary

The REDHOT II trial evaluating rapid emergency department outpatient management for heart failure has completed. Sponsored by Abbott RDx Cardiometabolic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Abbott RDx Cardiometabolic | Conditions: Heart Failure | NA | Status: COMPLETED